Aurich G
Folia Haematol Int Mag Klin Morphol Blutforsch. 1976;103(6):817-25.
During the immunotherapy children suffered from acute leukaemias will have a significantly higher transformation rate than at the beginning of the immunotherapy. This may be explained by an increase of the immunological competence as well as by an enhanced mobilization of lymphatic cells. Leukaemic blasts used for immunoinduction-therapy will have no higher transformation rates as antigens than those cells never contacted by children. During the immunotherapy an increase of transformation rates may be observed after administering unspecific antigens and in mixed cultures. In a retrospective manner the indication for immunotherapy may be checked again in children with immunotherapy on the basis of the clinical course and evaluation of the cellular immunoreaction.
在免疫治疗期间,患有急性白血病的儿童的转化率将比免疫治疗开始时显著更高。这可能是由于免疫能力的提高以及淋巴细胞动员的增强所致。用于免疫诱导治疗的白血病原始细胞作为抗原的转化率不会高于儿童从未接触过的那些细胞。在免疫治疗期间,给予非特异性抗原后以及在混合培养中可能会观察到转化率的增加。可以根据临床病程和细胞免疫反应评估,以回顾性方式再次检查接受免疫治疗的儿童的免疫治疗指征。